HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells
about
Gene expression profile of HIV-1 Tat expressing cells: a close interplay between proliferative and differentiation signalsMagnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuseThe cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disordersRecent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiologyHIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors.Amphetamine toxicities: classical and emerging mechanisms.Platelet-derived growth factor-BB restores HIV Tat -mediated impairment of neurogenesis: role of GSK-3β/β-catenin.Platelet-derived growth factor CC-mediated neuroprotection against HIV Tat involves TRPC-mediated inactivation of GSK 3beta.Genetic predictor of working memory and prefrontal function in women with HIV.HIV-1 proteins, Tat and gp120, target the developing dopamine systemEarly minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease.Increased Sensitivity to Cocaine Self-Administration in HIV-1 Transgenic Rats is Associated with Changes in Striatal Dopamine Transporter Binding.Neurotoxic profiles of HIV, psychostimulant drugs of abuse, and their concerted effect on the brain: current status of dopamine system vulnerability in NeuroAIDSDopaminergic marker proteins in the substantia nigra of human immunodeficiency virus type 1-infected brains.HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomesEvidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium.Yin and Yang of PDGF-mediated signaling pathway in the context of HIV infection and drug abuse.Involvement of TRPC channels in CCL2-mediated neuroprotection against tat toxicityTRPC channel-mediated neuroprotection by PDGF involves Pyk2/ERK/CREB pathway.Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.Neuronal toxicity in HIV CNS diseaseTRPC Channels: Prominent Candidates of Underlying Mechanism in Neuropsychiatric Diseases.Selective Vulnerability of Striatal D2 versus D1 Dopamine Receptor-Expressing Medium Spiny Neurons in HIV-1 Tat Transgenic Male Mice.HIV, Tat and dopamine transmission.Programmed neuronal cell death induced by HIV-1 tat and methamphetamine.Mechanisms of Cognitive Aging in the HIV-Positive Adult.A GluN2B-Selective NMDAR Antagonist Reverses Synapse Loss and Cognitive Impairment Produced by the HIV-1 Protein Tat.The role of human dopamine transporter in NeuroAIDS.Neurotoxicity of HIV-1 Tat protein: involvement of D1 dopamine receptorEarly impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation.
P2860
Q24795458-50098157-A88E-4717-B582-AAAAF8F65318Q26746336-A6E3C7C7-FE7A-4B3F-A9EC-245CEEEF9184Q26777952-1DF33DE3-7986-45C9-85F5-5878097AC54CQ28260273-33ECEE03-3D6F-4D28-AAA8-DA34E0B9C1DDQ32061182-9ABEA182-09F8-48CF-A99B-0CB83911E73DQ34102002-F541BC04-6A9C-46B3-8B2D-CB9D39C87CE0Q34281340-C37B179A-27A8-4CD0-BCC7-AAD283D0C820Q34450960-58CEF422-1426-492A-B530-3978A455FEA6Q35058518-EA9346E6-E4D2-485B-B710-A0DE4EE1DF18Q35743630-EAA7AD67-22B0-49AD-A178-493846D20C06Q35965672-1217D546-9860-4D39-9383-BD2EC2A534D9Q36429675-55448093-4DEA-4CE6-B7EF-0D670D8B0C78Q36856162-CBF6C3F4-E1FE-4222-9193-968D74326E8FQ37009432-7641E3F5-85D0-4CAB-BE58-AC33F4FFC7E0Q37196323-0B9A7153-B9A1-4029-BCC9-699F5AD84A5DQ37238426-49ADF1E4-0400-4BE6-B371-FAF0F396D8C9Q37366558-3ED5647D-8392-4F20-A485-199212D1C23CQ37397206-56C8ED1C-D07F-4598-BEB7-4C053DB11915Q37401453-6EF19B5C-3E5E-4887-B027-9F99671FDC46Q37441375-73C7373B-B53D-4D86-8148-996DD87784E2Q37547409-4E8BFAB8-20CB-437E-AD16-9C7B7F88F207Q38101560-E12E4A5F-D556-4CAC-B88E-2479DD9B4ED8Q38287204-E90511A4-B6E9-4B80-B498-0FACAA3CB5C3Q38803243-B3BB1009-E50D-4F7F-9E68-647B4B981D1AQ38812005-F0EBC4D9-202B-476D-8F45-D7F276B2399DQ39544439-6437F212-39A8-4C7D-85FB-D1E6E280A488Q40070860-E560FF61-0306-4913-AFF0-A91CF58972FFQ40119317-4710C3A7-BD3E-4352-8731-9633CA05917CQ41922188-AAB4BFE4-737E-4E88-B75E-4A3D0C65F153Q42408293-BF4DCC96-980A-4108-9E05-368BE04E929FQ42484653-B928E157-08B7-4076-AA1F-A7218F74A263
P2860
HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@ast
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@en
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@nl
type
label
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@ast
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@en
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@nl
prefLabel
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@ast
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@en
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@nl
P2093
P2860
P50
P3181
P356
P1476
HIV-1 Tat-mediated inhibition ...... in dopaminergic neuronal cells
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.275.6.4159
P407
P577
2000-02-11T00:00:00Z